Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Leber's Congenital Amaurosis Stories

2013-06-25 12:30:04

National research foundation awards $1.2 million to scientists in Italy, Netherlands and U.S. conducting groundbreaking research to find a cure for macular degeneration and other retinal diseases CONSHOHOCKEN, Pa., June 25, 2013 /PRNewswire-USNewswire/ -- The Macula Vision Research Foundation (MVRF), a national nonprofit focused on funding research to find a cure for macular degeneration and other retinal diseases including childhood blindness, announces their 2013-2014 grant...

2013-06-13 10:02:38

Engineered virus will improve gene therapy for blinding eye diseases Researchers at the University of California, Berkeley, have developed an easier and more effective method for inserting genes into eye cells that could greatly expand gene therapy to help restore sight to patients with blinding diseases ranging from inherited defects like retinitis pigmentosa to degenerative illnesses of old age, such as macular degeneration. Unlike current treatments, the new procedure — which...

2012-07-30 13:45:09

A five-country international team, led by Casey Eye Institute Molecular Diagnostic laboratory, BGI and Zhejiang University School of Medicine First Affiliated Hospital identified the NMNAT1 mutations as a cause of Leber congenital amaurosis (LCA), one of the most common causes of inherited blindness in children. The latest study was published online in Nature Genetics, reporting the genetic characteristics underlying some LCA patients, and providing important evidences that support NMNAT1 as...

2012-07-30 12:53:15

Researchers from the Massachusetts Eye and Ear Infirmary, The Children's Hospital of Philadelphia, Loyola University Chicago Health Sciences Division and their collaborators have isolated an elusive human gene that causes a common form of Leber congenital amaurosis (LCA), a relatively rare but devastating form of early-onset blindness. The new LCA gene is called NMNAT1. Finding the specific gene mutated in patients with LCA is the first step towards developing sight-saving gene therapy....

Image 1 - Gene Therapy For Inherited Blindness Succeeds In Patients' Other Eye
2012-02-10 04:53:45

In 3 Adults, Repeat Dose Safely Improves Vision Gene therapy for congenital blindness has taken another step forward, as researchers further improved vision in three adult patients previously treated in one eye. After receiving the same treatment in their other eye, the patients became better able to see in dim light, and two were able to navigate obstacles in low-light situations. No adverse effects occurred. Neither the first treatment nor the readministered treatment triggered an...

2012-02-09 10:03:00

-- In 3 Adults, Repeat Dose Safely Improves Vision -- A Joint News Release from The Children's Hospital of Philadelphia and the University of Pennsylvania PHILADELPHIA, Feb. 9, 2012 /PRNewswire-USNewswire/ -- Gene therapy for congenital blindness has taken another step forward, as researchers further improved vision in three adult patients previously treated in one eye. After receiving the same treatment in their other eye, the patients became better able to see in dim light, and...

2011-11-15 07:00:00

PHILADELPHIA, Nov. 15, 2011 /PRNewswire-USNewswire/ -- Researchers at Hadassah Hospital in Israel, led by Dr. Eyal Banin, have completed a clinical trial that tested the use of gene therapy to restore sight to patients suffering from Leber's Congenital Amaurosis (LCA). Dana and Yossi, two participants in this study, suffer from Leber's Congenital Amaurosis (LCA), the most severe form of all inherited retinal dystrophies causing congenital blindness. Like others affected, they have...

Gene Therapy May Improve Some Forms Of Blindness
2011-10-28 09:45:12

A UK man is being treated for the progressive genetic disorder, choroideraemia, in an attempt to reverse his blindness. Jonathan Wyatt was able to see normally until about the age of 19 when he began having problems seeing in the dark. He was told by doctors that his vision would get progressively worse until eventually going blind, reports BBC News. Poor eyesight didn´t stop Wyatt, now 63 years old, from a career as a barrister but 10 years ago he found himself having difficulty...

2011-05-10 12:02:00

- Hematologist and Gene Therapy Expert at The Children's Hospital of Philadelphia Joins an Elite Honorary Society - PHILADELPHIA, May 10, 2011 /PRNewswire-USNewswire/ -- Katherine A. High, M.D., a gene therapy expert at The Children's Hospital of Philadelphia, has been elected to the 2011 class of the American Academy of Arts and Sciences. The Academy is one of the nation's most prestigious honorary societies and is a leading center for independent policy research. Dr. High joins a...

2011-04-07 09:00:00

NEW YORK, April 7, 2011 /PRNewswire-USNewswire/ -- Every 18 months, the Macula Vision Research Foundation hosts a conference that brings together industry-leading retinal scientists, clinicians and medical equipment developers. This year, 25 participants were invited to share their work and collaborate with one another in an interactive setting at the Four Seasons Hotel in New York. Dr. Samuel G. Jacobson, M.D. Ph.D., Scheie Eye Institute, University of Pennsylvania, discussed his...